Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

Item
http://www.wikidata.org/entity/Q28379120
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityAntifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug actionPotent synergism of the combination of fluconazole and cyclosporine in Candida albicansCyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondiiDetailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparumNovel paradigms for drug discovery: computational multitarget screeningFluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.Inhibitory effect of aureobasidin A on Toxoplasma gondiiThiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.Role of P glycoprotein in the course and treatment of Encephalitozoon microsporidiosisFungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisitionCpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycleHost cell P-glycoprotein is essential for cholesterol uptake and replication of Toxoplasma gondii.In silico analysis of the cyclophilin repertoire of apicomplexan parasites.
P2860

Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

Item
http://www.wikidata.org/entity/Q28379120
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@ast
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@en
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@nl
type
label
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@ast
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@en
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@nl
prefLabel
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@ast
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@en
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@nl
P1433
P1476
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932
P1433
P1476
Characterization of anti-Toxop ...... otein in Toxoplasma physiology
@en
P2093
P2860
P304
P31
P407
P433
P478
P577
P698
P932